U.S. federal trademark · Serial No. 74617224 · Reg. No. 510590
ovarian cancer vaccine based on a murine monoclonal antibody and an ovarian cancer pharmaceutical preparation for vaccination consisting of the monoclonal antibody supplied in a proprietary formulation for intravenous, subcutaneous, intraperitoneal or intramuscular injection in humans
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.